Incorporated in May '92 as a public limited company, Kilitch Drugs (India) (KDIL) went public in Feb.'94 to created and deployed a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.'95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical.

A Pharmaceutical formulation plant at Sana'a Republic of Yemen was created and deployed at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also broadened its footprint operations into into an agreement with a Miami company for the export of their medicine to West Indies, south and central America.

The company broadened its footprint operations into into a contract with one of the leading company in the Republic of Yemen which it had created and deployed at a cost of Rs 2.5-cr tanning unit, which was implemented in the year 1995-96. The company had created and deployed a bulk drug unit at Patalganga, Maharashtra for producing raw materials for formulations. The company exports to Sudan, Yemen, middle-east, Miami and certain south American companies.

KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus, Bon-Bon Gripe Water and Kilitch Balm.